Anti-Müllerian hormone: clinical insights into a promising biomarker of ovarian follicular status.
about
Anti-mullerian hormone as a predictor of time to menopause in late reproductive age womenContribution of the rate of change of antimüllerian hormone in estimating time to menopause for late reproductive-age womenDiscordances between follicle stimulating hormone (FSH) and anti-Müllerian hormone (AMH) in female infertility.Prediction of reproductive outcomes according to different serum anti-Müllerian hormone levels in females undergoing intracystoplasmic sperm injectionThe correlations of anti-mullerian hormone, follicle-stimulating hormone and antral follicle count in different age groups of infertile womenSerum antimüllerian hormone in healthy premenopausal women.Age-specific serum anti-mullerian hormone and follicle stimulating hormone concentrations in infertile Iranian women.An analysis of the influence of selected genetic and hormonal factors on the occurrence of depressive symptoms in late-reproductive-age women.Cut-Off Levels of Anti-Mullerian Hormone for The Prediction of Ovarian Response, In Vitro Fertilization Outcome and Ovarian Hyperstimulation Syndrome.The anti mullerian hormone- a novel marker for assessing the ovarian reserve in women with regular menstrual cyclesAssociation between individual ovarian dimensions with ovarian reserve indices.Serum anti-Müllerian hormone and inhibin B levels at ovulation triggering day can predict the number of immature oocytes retrieved in in vitro fertilization cycles."Anti-Mullerian Hormone: Marker for Ovarian Response in Controlled Ovarian Stimulation for IVF Patients": A First Pilot Study in the Indian PopulationFollicular-fluid anti-Mullerian hormone (FF AMH) is a plausible biochemical indicator of functional viability of oocyte in conventional in vitro fertilization (IVF) cycles.Biomarkers of Ovarian Reserve.Serum anti-Müllerian hormone predicts ovarian response and cycle outcome in IVF patients.Different serum anti-Müllerian hormone concentrations are associated with oocyte quality, embryo development parameters and IVF-ICSI outcomes.Protective effect of alpha-lipoic acid in methotrexate-induced ovarian oxidative injury and decreased ovarian reserve in rats.Curcumin Exerts a Protective Effect against Premature Ovarian Failure in Mice.Goserelin can inhibit ovarian cancer proliferation and simultaneously protect ovarian function from cisplatin: an in vitro and in vivo study.Evaluation of the effects of fulvestrant and micronized progesterone on the post-operative adhesion formation and ovarian reserve in rat model with immunohistochemical and biochemical analysis.Biology and biotechnology of follicle development
P2860
Q28383911-3AA5781E-7DFE-40FA-9C01-BC4123A42143Q28390089-4CC9C433-EC32-49B4-A0B8-B81DA5E28F7AQ33952002-8BC05F6C-EDEA-4F13-A575-BE9BAEF6CB82Q34999705-DB555F75-12E6-491C-AABF-0963138452DCQ35166382-CC4D622D-504A-417D-A87A-6ECD3A3C1960Q35185385-E407B1BD-B649-4384-AAA6-447EC1832976Q35538995-637C080C-9DED-4D57-AAD1-18870D59FE2FQ35539680-BD86F1CA-462C-46A3-B3AF-E9662937060EQ35898934-A437A6E0-BF9F-4A46-92BF-481779916ED5Q36554078-12EA78E4-015C-4FA8-8435-A2054A8474B7Q36651869-A02F3F9F-D578-4467-9A22-7FC07C4500C6Q36853993-C948BBAB-F669-4407-8AC4-EB6BC2FB1F2CQ37147174-269ED79E-D7E8-44AD-9B34-16DF7DE2BC3EQ37186656-2D5B250A-FD08-48C5-91DF-E7FF25411B37Q37207292-D54A94E2-72CD-416C-AD78-DB7CCD003AF9Q37380100-DD9C1311-FD79-4B67-B7AC-E0B9FBF1BCD7Q42491370-D812B64D-F000-4F61-AE13-8E2FFD4783B3Q47809528-B01917E7-2BE0-4D93-94A0-8CE0C7B4A990Q50043551-F88C8812-AA71-4FE5-B9E0-9AEB043CF472Q50984893-952667A0-50B9-4396-95AB-806A89E5EC39Q50993758-FED4B3D1-9A54-4D96-A762-B072608B2552Q58915139-006DBE34-8B1C-435A-B776-4E07045835D9
P2860
Anti-Müllerian hormone: clinical insights into a promising biomarker of ovarian follicular status.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Anti-Müllerian hormone: clinic ...... of ovarian follicular status.
@ast
Anti-Müllerian hormone: clinic ...... of ovarian follicular status.
@en
type
label
Anti-Müllerian hormone: clinic ...... of ovarian follicular status.
@ast
Anti-Müllerian hormone: clinic ...... of ovarian follicular status.
@en
prefLabel
Anti-Müllerian hormone: clinic ...... of ovarian follicular status.
@ast
Anti-Müllerian hormone: clinic ...... of ovarian follicular status.
@en
P2093
P1476
Anti-Müllerian hormone: clinic ...... of ovarian follicular status.
@en
P2093
Daniel H Méndez Lozano
Estelle Feyereisen
Joëlle Taieb
Laetitia Hesters
Renato Fanchin
René Frydman
P304
P356
10.1016/S1472-6483(10)61081-4
P577
2006-06-01T00:00:00Z